Web Search Site Search HCV Patient Assistance Programs (click here for details)   Merck Zepatier Patient Assistance Program (click here for details)   Abbvie - Vikiera Pak Patient Support Program (click here for details)   Sofosbuvir (Sovaldi) - Gilead U.S. Patient Assistance Program (click here for details)   Ryan White Care Act Hepatitis C & B Language (click here for details)   HCV Copayment Assistance - HealthWell Foundation (click here for details)   Current HIV Articles and News Updates     HIV     IAS: HIV Prevention at IAS 2015 Vancouver - Jared Baeten, MD PhD Connie Celum, MD MPH University of Washington   IAC: HIV Prevention at AIDS 2016 21st International AIDS Conference Durban, South Africa 18-22 July 2016 Jared Baeten, MD PhD Connie Celum, MD MPH University of Washington- (08/08/16)   IAC: 21st International AIDS Conference July 18-22, 2016 Durban, South Africa - Eric S. Daar, M.D. Chief, Division of HIV Medicine Harbor-UCLA Medical Center Professor of Medicine David Geffen School of Medicine at UCLA - (08/05/16)   AGE: Non-HIV care provider....Aging, Worse Still to Come?....Aging Clinic at Weill-Cornell, NYC; aging $costs in HIV skyrocket - (09/29/16)   AGE: People 60 or Older Gain Fewer CD4s on ART Through 48 Months - Mark Mascolini (09/29/16)   Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration - (09/28/16)   Generics HIV ART PK Risky? - (09/28/16)   Editorial - The Cognition-Kidney Disease Connection: Lessons From Population-Based Studies in the United States - (09/28/16)   Strong Leg Muscles Improve Brain Functioning - 2 studies report - (09/28/16)   AGE: Excess Mitochondrial DNA Damage in Brain of People With HIV - written by Mark Mascolini - (09/28/16)   AGE: Frailty and the Risk of Falls in HIV-Infected Older Adults in the ACTG A5322 Study - (09/28/16)   AGE: Longitudinal Study of Falls among HIV-infected and Uninfected Women: Results from the Women's Interagency HIV Study - (09/28/16)   AGE: Worse Neurocognitive Score Tied to Higher CMV, Longer HIV, Lower BP - written by Mark Mascolini - (09/28/16)   AGE: Transitions from Disability to Ability: A Qualitative Study to Understand Exercise Barriers in Older, HIV-Infected Adults - (09/28/16)   IWCADRH: CT Signals of Chronic Lung Disease in HIV Patients Who Never Smoked - Mark Mascolini - (09/28/16)   More HIV Articles...         News Updates     New Orleans group joins federal complaint against HIV drug costs/ lawsuit vs Humana for overcharges/access - (09/26/16)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     EASL: Summary from EASL 2016 for Hepatitis C Highly efficacious pan-genotypic DAA combinations on their way: the last gaps in difficult-to-treat patient populations are going to be closed soon. - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany   Cluster of Sexually Transmitted Hepatits C Virus Among the MSM Population in Southeast Michigan [Detroit] - (09/28/16)   Special EASL: Barriers To HCV Treatment in Methadone Users / Philadelphia Study-Temple University - (09/27/16)   Special EASL: Meta-Analysis of the Real-World Effectiveness of Ombitasvir/Paritaprevir ritonavir ± Dasabuvir ± Ribavirin in Patients With HCV Genotype 1 or 4 Infection - (09/26/16)   Special EASL: Ribavirin Management in HCV Genotype 4 Patients Receiving Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in the Phase 3 AGATE-I Study - (09/26/16)   Special EASL: Analysis of Baseline Variants in GT1a-Infected Pati ents Treated With 3D With and Without RBV, and Cirrhotic GT1a Patients Treated With 3D Plus RBV for 12 or 24 Weeks - (09/26/16)   Special EASL: GEODE-II: Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Patients With Genotype 1a Chronic Hepatitis C Virus Infection Without Cirrhosis - (09/26/16)   More Hep C Articles...         Hepatitis B     New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus - (09/19/16)   "Curing" HBV - New Drugs - (09/19/16)   Fueled by heroin crisis, hepatitis B cases rise in Maine - (09/09/16)   Curing HBV, New Drugs - [HBV at EASL 2016] - (09/09/16)   Sliding Down the Cascade of Care for Chronic Hepatitis B Virus Infection - Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings - (09/09/16)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 6th International Workshop of HIV & Women pre CROI 20 February 2016 - 21 February 2016 Boston http://www.virology-education.com/event/upcoming/international-workshop-hiv-women-2016/   https://www.informedhorizons.com/resistance2016/   http://www.croiconference.org/   http://apasl.info/ www.apasl2016.org   4th Optimize Workshop, Using DAAs in Patients with Cirrhosis and Liver Recipients Barcelona, Spain on 12 April 2016 preceding the EASL previously known as International Workshop on Optimal Use of DAAs in Advanced Liver Disease and Transplantation 4th Optimize Workshop http://www.virology-education.com/event/upcoming/4th-optimize-workshop-2016/   http://ilc-congress.eu/   http://www.nyas.org/Events/Detail.aspx?cid=cabdc6b9-66f8-47b1-9668-33fbaccca6e9   http://www.hivhepamericas.org/   http://www.ddw.org/   14th European Meeting on HIV & Hepatitis 2016 25 May 2016 - 27 May 2016 Rome, Italy It is our pleasure to announce that the 11th International Workshop on Hepatitis C: Resistance and New Compounds will be organized as a half day program in the 14th European Meeting on HIV & Hepatitis (Rome, Italy, 25 - 27 May 2016). European Meeting o HIV & Hepatitis - Treatment strategies & Antiviral Drug Resistance preliminarily scheduled to take place on 25 - 27 May 2016 in Rome, Italy. http://www.virology-education.com/event/upcoming/14th-european-hiv-hepatitis-workshop-2016/   Asian Conference on Hepatitis and AIDS 2016 http://www.virology-education.com/event/upcoming/5th-acha-2016/   12th Co-Infection Workshop 2016 Berlin, Germany 2 - 3 June 2016 http://www.virology-education.com/event/upcoming/12th-co-infection-workshop-2016/   HIV & hepatitis Clinical Pharmacology Workshop 2016 8 June 2016 - 10 June 2016 Washington DC, USA http://www.virology-education.com/event/upcoming/17th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-therapy/   Boston, Massachusetts, United States 16 - 20 June 2016 http://www.asmmicrobe.org/   HIV Pediatrics Workshop 2016 15 July 2016 - 16 July 2016 Durban, South Africa http://www.virology-education.com/event/upcoming/hiv-pediatrics-workshop-2016/   http://www.aids2016.org/   Viral Hepatitis Congress 2016 8-10 September 2016 in New York, USA http://www.viral-hep.org/   International Viral Hepatitis Elimination Meeting 2016 22 September 2016 (tbc) Location: Paris, France http://www.virology-education.com/event/upcoming/european-roundtable-hep-cure-elimination/   The New York Academy of Sciences, New York, 12 - 13 September 2016 http://www.intmedpress.com/comorbidities/   7th HIV & AGING WORKSHOP 2106 26 September 2016 - 27 September 2016 Washington, DC, USA http://www.virology-education.com/event/upcoming/7th-hiv-aging-2016/   2nd Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 6-7 October 2016 Romania   http://www.virology-education.com/event/upcoming/2nd-central-eastern-european-meeting-viral-hepatitis-co-infection-hiv/   23-26 October 2016, Glasgow, UK http://hivglasgow.org/   http://www.idweek.org/   http://www.aasld.org/events-professional-development/liver-meeting   7th International Workshop on HIV and Aging September 26-27, 2016 Washington, DC   Paris Special EASL Meeting Pais, France September 23-24, 2016   18th International Workshop on Comorbidities and Adverse Drug Reactions in HIV, September 12-13, 2016, New York   International AIDS Conference Durban, South Africa July 18-22, 2016   ASM/ICAAC June 16-20 2016 Boston MA   17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy June 8-10, 2016, Washington DC   DDW - Digestive Disease Week 2016 San Diego, CA May 16-19, 2016   The International Liver Congress™ EASL - European Association for the Study of the Liver Barcelona, Spain 13-17 April 2016   Conference on Retroviruses and Opportunistic Infections (CROI) February 22-25, 2016, Boston MA   APASL 25th Conference of the Asian Pacific Association for the Study of the Liver Feb 20-24 2016, Tokyo, Japan   HEPDART 2015: Frontiers in Drug Development for Viral Hepatitis December 6-10 2015 Wailea, HI   66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015   (IWCADRH) 17th Intl Workshop on Comorbidities and Adverse Drug Reactions in HIV Oct 20-22 2015, Barcelona, Spain   15th European AIDS Conference (EACS) October 21-24, 2015 Barcelona   IDSA/IDWeek October 7-11 2015 San Diego   6th International Workshop on HIV and Aging October 5-6, 2015 Washington, DC   ICAAC 2015 55th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2015, San Diego, CA   IAS 2015: 8th IAS Conference on HIV Pathogenesis Treatment and Prevention Vancouver Canada 18-22 July 2015   16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 26-28, 2015 Washington, DC   DDW - Digestive Disease Week 2015 May 16-19, 2015 Washington DC United States   EASL - The International Liver Congress 2015 50th Annual Meeting of the European Association for the Study of the Liver Vienna, Austria April 22-26   The 24th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2015) Istanbul, Turkey, March 12-15, 2015   22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015   65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014   HIV Drug Therapy Glasgow November 2-6, 2014 Glasgow, UK   5th International Workshop on HIV and Aging. October 21-22, 2014 Baltimore   ACG Annual Scientific Meeting Philadelphia, PA, October 20, 2014   16th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV Philadelphia USA Oct 6-8, 2014   ID Week Oct 8-12 2014 Philadelphia   AASLD/EASL Special Conference on Hepatitis C New York City, New York September 12 - 13   ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2014 Washington, DC   20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   14th European AIDS Conference Oct 16-19 2013 Brussels, Belgium   ID Week October 2-6, 2013 San Francisco   53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13 2013, Denver CO   IAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30 - July 3 2013 Kuala Lumpur, Malaysia   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 4-8, 2013 Toronto, Canada   (APASL) 23rd Conference of the Asian Pacific Association for the Study of the Liver 6-9 June, 2013, Singapore   Digestive Disease Week (DDW) May 18-21, 2013 Orlando, FL   14th International Workshop on Clinical Pharmacology of HIV Therapy April 22-24, 2013 The Netherlands, Amsterdam   EASL 48th Annual Meeting April 24th - 28th 2013 The Netherlands, Amsterdam   CROI: 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013   Third International Workshop on HIV and Women January 14-15, 2013 Toronto 15th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Brussels, Belgium Oct 15-17 2013 11th International Congress on Drug Therapy in HIV Infection 11-15 November 2012 Glasgow, UK 63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 3rd International Workshop on HIV and Aging November 5-6, 2012 Baltimore MD IDSA Conference (Infectious Disease Society Association) San Diego, CA Oct 17-21 2012 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 9-12, 2012, San Francisco XIX International AIDS Conference July 22-27, 2012 Washington, DC   14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Washington DC, July 19-21 2012   International Workshop on HIV & Hepatitis Virus Drug Resistance 5-9 June 2012, Sitges, Spain   EASL 47th Annual Meeting Barcelona, Spain April 18th - 22nd 2012   13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012   CROI: 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012   The 22st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 16-19, 2012 Taipei, Taiwan   2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377